271 related articles for article (PubMed ID: 25029126)
1. Multidrug resistance among Acinetobacter baumannii isolates from Iran: changes in antimicrobial susceptibility patterns and genotypic profile.
Bahador A; Raoofian R; Taheri M; Pourakbari B; Hashemizadeh Z; Hashemi FB
Microb Drug Resist; 2014 Dec; 20(6):632-40. PubMed ID: 25029126
[TBL] [Abstract][Full Text] [Related]
2. Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Bahador A; Taheri M; Pourakbari B; Hashemizadeh Z; Rostami H; Mansoori N; Raoofian R
Microb Drug Resist; 2013 Oct; 19(5):397-406. PubMed ID: 23768166
[TBL] [Abstract][Full Text] [Related]
3. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
5. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z
J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392
[TBL] [Abstract][Full Text] [Related]
6. Changes in MIC within a global collection of Acinetobacter baumannii collected as part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009.
Morfin-Otero R; Dowzicky MJ
Clin Ther; 2012 Jan; 34(1):101-12. PubMed ID: 22177546
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
8. Distribution of bla(OXA-23), ISAba , Aminoglycosides resistant genes among burned & ICU patients in Tehran and Sari, Iran.
Nasrolahei M; Zahedi B; Bahador A; Saghi H; Kholdi S; Jalalvand N; Esmaeili D
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():38. PubMed ID: 25252850
[TBL] [Abstract][Full Text] [Related]
9. Clonal spread of multidrug-resistant Acinetobacter baumannii in eastern Taiwan.
Chang KC; Lin MF; Lin NT; Wu WJ; Kuo HY; Lin TY; Yang TL; Chen YC; Liou ML
J Microbiol Immunol Infect; 2012 Feb; 45(1):37-42. PubMed ID: 22154678
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
[TBL] [Abstract][Full Text] [Related]
11. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
12. Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.
Bahador A; Farshadzadeh Z; Raoofian R; Mokhtaran M; Pourakbari B; Pourhajibagher M; Hashemi FB
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):24. PubMed ID: 29859115
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
Mataracı Kara E; Yılmaz M; Özbek Çelik B
J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
[TBL] [Abstract][Full Text] [Related]
14. Clonal evolution multi-drug resistant Acinetobacter baumannii by pulsed-field gel electrophoresis.
Mohajeri P; Farahani A; Feizabadi MM; Norozi B
Indian J Med Microbiol; 2015; 33(1):87-91. PubMed ID: 25560008
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
[TBL] [Abstract][Full Text] [Related]
16. Role of insertion sequence Aba-1 and AdeS in reduced tigecycline susceptibility in MDR-Acinetobacter baumannii clinical isolates from Cairo, Egypt.
Hassan R; Mukhtar A; Hasanin A; Ghaith D
J Chemother; 2018 Apr; 30(2):89-94. PubMed ID: 29108486
[TBL] [Abstract][Full Text] [Related]
17. Is minocycline a solution for multidrug-resistant Acinetobacter baumannii?
Neonakis IK; Spandidos DA; Petinaki E
Future Microbiol; 2014; 9(3):299-305. PubMed ID: 24762305
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Cai X; Yang Z; Dai J; Chen K; Zhang L; Ni W; Wei C; Cui J
Int J Antimicrob Agents; 2017 May; 49(5):609-616. PubMed ID: 28315729
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran.
Safari M; Saidijam M; Bahador A; Jafari R; Alikhani MY
J Res Health Sci; 2013 Sep; 13(2):162-7. PubMed ID: 24077474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
